launch in early January 2026
A patient with genetic variants linked to higher hunger drive may benefit from remaining at the lower end of the calorie range (1,2001,400) or combining semaglutide with a complementary approach, while someone with lower baseline appetite might thrive at 1,6001,800 calories while still losing weight steadily
Commenting on the MHRA review, Steve Bazire, honorary professor at the University of East Anglia School of Pharmacy, said: The 2024 [disproportionality] study was useful as it raised the possibility of a problem that then needs investigating
If pregnant or lactating, consult your physician before using this product
Purity Standards & USA Synthesis
doi: 10.1016/S0168-8278(22)01680-4 27